Long-Term Outcomes of Congenital Adrenal Hyperplasia.

Authors:
Nordenström A; Lajic S; Falhammar H.

Journal:
Endocrinol Metab (Seoul)

Publication Year: 2022

DOI:
10.3803/EnM.2022.1528

PMCID:
PMC9449109

PMID:
35799332

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Endocrinol Metab (Seoul)

Abbreviation: Endocrinol Metab (Seoul)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency.
Charoensri S; Auchus RJ. (2024) - Transparency Score: 2/6
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option wit…
Yoon JH; Choi W; Park JY and 3 more (2024) - Transparency Score: 4/6
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.
Kim MJ; Moon JH; Lee EK and 7 more (2024) - Transparency Score: 3/6
FoxO6-Mediated TXNIP Induces Lipid Accumulation in the Liver through NLRP3 Inflammasome Activation.
Kim ME; Lee JS; Kim TW and 2 more (2024) - Transparency Score: 3/6
Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator.
Min SH; Song DK; Lee CH and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported."

Evidence found in paper:

"This study was funded by the Magnus Bergvall foundation, the Stockholm County Council (ALF-SLL), Swedish Research Council (DNR 2021-02440), Region Stockholm (clinical research appointment DNR RS 2019-1140 to Svetlana Lajic), Karolinska Institutet, and Stiftelsen Frimurare Barnhuset i Stockholm."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025